{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:51:36Z","timestamp":1761979896586,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jasc.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T18:27:58Z","timestamp":1618943278000},"page":"399-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening"],"prefix":"10.1016","volume":"10","author":[{"given":"Ming","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Shlyakhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata A.","family":"Tinnirello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich M.","family":"Sturgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2021.04.002_bib1","first-page":"12","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jasc.2021.04.002_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/LGT.0000000000000103","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"19","author":"Huh","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2021.04.002_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2021.04.002_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jasc.2019.06.001","article-title":"A review of the FDA-approved molecular testing platforms for human papillomavirus","volume":"8","author":"Salazar","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2021.04.002_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5858\/133.5.743","article-title":"Recommended principles and practices for validating clinical molecular pathology tests","volume":"133","author":"Jennings","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jasc.2017.10.003","article-title":"Performance of Roche cobas high-risk human papillomavirus (hrHPV) testing in the two most common liquid-based Papanicolaou test platforms","volume":"7","author":"Fuller","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2021.04.002_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5858\/arpa.2015-0027-OA","article-title":"A comparison of the roche cobas HPV test with the Hybrid Capture 2 test for the detection of high-risk human papillomavirus genotypes","volume":"140","author":"Levi","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2014.10.014","article-title":"Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology","volume":"135","author":"Rebolj","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2021.04.002_bib10","doi-asserted-by":"crossref","first-page":"e86835","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"e59765","DOI":"10.1371\/journal.pone.0059765","article-title":"Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay","volume":"8","author":"Preisler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"e0149611","DOI":"10.1371\/journal.pone.0149611","article-title":"Cervical cytology specimen stability in Surepath preservative and analytical sensitivity for HPV testing with the cobas and Hybrid Capture 2 tests","volume":"11","author":"Tardif","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2021.04.002_bib13","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2018.180734","article-title":"Clinical performance of SurePath preservative compared to PreservCyt(R) with Cobas(R) and Hybrid Capture(R) 2 HPV tests in a colposcopy population","volume":"65","author":"Pyne","year":"2019","journal-title":"Clin Lab"},{"key":"10.1016\/j.jasc.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ajcp\/aqx091","article-title":"Performance of the cobas HPV test for the triage of atypical squamous cells of undetermined significance cytology in cervical specimens collected in SurePath","volume":"148","author":"Tewari","year":"2017","journal-title":"Am J Clinc Pathol"},{"key":"10.1016\/j.jasc.2021.04.002_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cyt.12311","article-title":"Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities","volume":"27","author":"Fornari","year":"2016","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2021.04.002_bib16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/modpathol.3800290","article-title":"Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents","volume":"18","author":"Hu","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1128\/JCM.02716-14","article-title":"Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening","volume":"52","author":"Boers","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jasc.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/jclinpath-2013-202014","article-title":"Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H)","volume":"67","author":"Cubie","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jasc.2021.04.002_bib20","doi-asserted-by":"crossref","first-page":"e0182854","DOI":"10.1371\/journal.pone.0182854","article-title":"Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival","volume":"12","author":"Nogueira Dias Genta","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294521000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294521000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:44Z","timestamp":1761979604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294521000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213294521000442"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2021.04.002","relation":{},"ISSN":["2213-2945"],"issn-type":[{"type":"print","value":"2213-2945"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}